U.S. markets closed

Ligand Pharmaceuticals Incorporated (LGND)

NasdaqGM - NasdaqGM Real Time Price. Currency in USD
65.72-2.11 (-3.11%)
At close: 04:00PM EST
69.01 +3.29 (+5.01%)
After hours: 04:57PM EST
Full screen
Trade prices are not sourced from all markets
Gain actionable insight from technical analysis on financial instruments, to help optimize your trading strategies
Chart Events
Neutralpattern detected
Commodity Channel Index

Commodity Channel Index

Previous Close67.83
Bid65.68 x 1000
Ask66.07 x 800
Day's Range65.45 - 68.46
52 Week Range45.27 - 102.83
Avg. Volume219,052
Market Cap1.11B
Beta (5Y Monthly)1.00
PE Ratio (TTM)44.71
EPS (TTM)1.47
Earnings DateFeb 15, 2023 - Feb 20, 2023
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateJul 02, 2010
1y Target Est110.83
Fair Value is the appropriate price for the shares of a company, based on its earnings and growth rate also interpreted as when P/E Ratio = Growth Rate. Estimated return represents the projected annual return you might expect after purchasing shares in the company and holding them over the default time horizon of 5 years, based on the EPS growth rate that we have projected.
Fair Value
Near Fair Value
12% Est. Return

Subscribe to Yahoo Finance Plus to view Fair Value for LGND

View details
Research that delivers an independent perspective, consistent methodology and actionable insight
Related Research
  • Ligand Pharmaceuticals Incorpor
    LGND: Lowering target price to $85.00LIGAND PHARMACEUTICALS has an Investment Rating of BUY; a target price of $85.000000; an Industry Subrating of High; a Management Subrating of Medium; a Safety Subrating of Medium; a Financial Strength Subrating of Medium; a Growth Subrating of Medium; and a Value Subrating of High.
    Fair Value
    Economic Moat
    8 days agoArgus Research
View more